Usa covid-19 vaccine Coronavirus Usa

Pfizer shares jump 9% as parent's potential covid-19 drug shows positive result

Reading now: 830
www.livemint.com

₹4172.60 on Thursday after the company's US-based parent reported positive preliminary results from a joint project to develop coronavirus vaccine.At 12:30 pm, Pfizer shares were at ₹4163.95, up 4.76% from the previous close, while the benchmark index, Sensex gained 1.25% to 35856.53.BioNTech and Pfizer pick the most promising of four experimental vaccines for a trial, involving up to 30,000 healthy participants, that is likely to begin in the United States and Europe in late July, if it gets the regulatory green light.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA